ME2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.317790E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.341200E-01
Normal-vs-Stage2
9.284500E-03
Normal-vs-Stage3
1.636360E-02
Normal-vs-Stage4
9.404400E-02
Stage1-vs-Stage2
3.104800E-01
Stage1-vs-Stage3
8.485500E-02
Stage1-vs-Stage4
4.766400E-01
Stage2-vs-Stage3
1.209780E-01
Stage2-vs-Stage4
8.710200E-01
Stage3-vs-Stage4
1.586640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.122400E-02
Normal-vs-AfricanAmerican
3.512600E-01
Normal-vs-Asian
1.617830E-02
Caucasian-vs-AfricanAmerican
1.227630E-01
Caucasian-vs-Asian
2.576800E-01
AfricanAmerican-vs-Asian
7.663800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.777400E-03
Normal-vs-Female
5.379600E-02
Male-vs-Female
1.008060E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.575700E-02
Normal-vs-Age(41-60Yrs)
4.253500E-02
Normal-vs-Age(61-80Yrs)
1.052250E-02
Normal-vs-Age(81-100Yrs)
2.694200E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.162400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.294400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.098400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.782400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.616600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.780800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.950300E-04
Normal-vs-Daily Drinker
7.556700E-04
Normal-vs-Weekly Drinker
8.883500E-02
Normal-vs-Occasional Drinker
7.271700E-02
Normal-vs-Social Drinker
1.245400E-01
Non Drinker-vs-Daily Drinker
4.102800E-01
Non Drinker-vs-Weekly Drinker
2.691400E-01
Non Drinker-vs-Occasional Drinker
1.643780E-01
Non Drinker-vs-Social Drinker
6.125800E-02
Daily Drinker-vs-Weekly Drinker
9.329500E-02
Daily Drinker-vs-Occasional Drinker
5.591600E-02
Daily Drinker-vs-Social Drinker
1.420360E-02
Weekly Drinker-vs-Occasional Drinker
9.384200E-01
Weekly Drinker-vs-Social Drinker
5.918400E-01
Occasional Drinker-vs-Social Drinker
6.142600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.064000E-01
Normal-vs-Grade 2
9.857200E-01
Normal-vs-Grade 3
9.902200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.632400E-01
Grade 1-vs-Grade 3
3.016200E-01
Grade 1-vs-Grade 4
8.064000E-01
Grade 2-vs-Grade 3
6.610000E-01
Grade 2-vs-Grade 4
9.857200E-01
Grade 3-vs-Grade 4
9.902200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.106440E-02
Normal-vs-NonDiabetic
4.743600E-03
Diabetic-vs-NonDiabetic
8.516600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.359900E-03
Normal-vs-NoPancreatitis
7.798700E-03
Pancreatitis-vs-NoPancreatitis
1.615350E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.283700E-02
Normal-vs-N1
5.958500E-03
N0-vs-N1
5.618200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.52800000000309E-05
Normal-vs-TP53-NonMutant
5.512400E-02
TP53-Mutant-vs-TP53-NonMutant
1.442950E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
